Skip to Main Content

Paper Details

Opportunistic Infections After Induction With Alemtuzumab or Basiliximab: A 3-Year Kidney Transplantation Experience.
Transplant Proc
1
2021
Author NameAffiliation
Andre C KalilUniversity of Nebraska Medical Center
  • 1 - 1

Datasets

Release 1.2